The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
September 19th 2024
EDG-7500 was well-tolerated in healthy patients in Phase 1 while achieving gradient relief without LVEF reductions in the Phase 2 CIRRUS-HCM trial.
September 12th 2024
September 10th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
FREEDOM Study Reveals CABG is More Cost-Effective than PCI for Patients with Diabetes
November 6th 2012Study results presented at AHA 2012 indicate that revascularization using CABG in diabetic patients with multivessel disease provides better clinical outcomes than PCI and is more cost effective in the long run.
Chelation Therapy Does not Improve Quality of Life in Treated Heart Attack Patients
November 6th 2012Results from a sub-study of the Trial to Assess Chelation Therapy (TACT) that focused on quality of life issues in patients who had previously suffered a heart attack and were treated with chelation therapy reveal no improvements in these patients' quality of life.
Study Shows Tolvaptan is Effective in Treating Autosomal Dominant Polycystic Kidney Disease
November 4th 2012Results from the TEMPO trial presented at Kidney Week 2012 show that treatment with tolvaptan slowed the increase in total kidney volume and the decline in kidney function in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Reducing the Risk of Rejection Following Kidney Transplant in Patients with End-stage Renal Disease
November 2nd 2012The powerful immunosuppressive drugs used to prevent allograft rejection are associated with severe side effects. A "mixed chimerism" strategy in which patients undergo simultaneous bone marrow and kidney transplant from the same donor may improve transplant survival and reduce the need for these drugs.
Why is Peritoneal Dialysis Underutilized in the US Compared to Hemodialysis?
November 2nd 2012Use of peritoneal dialysis in patients with end-stage renal disease is declining due to lack of physician training and awareness, financial disincentives, and other factors. However, with proper patient and provider education, it is possible to grow a successful peritoneal dialysis program.
Clinical Characteristics and Management of Hyponatremia
October 18th 2012Hyponatremia is frequently seen in patients with hepatic impairment and portal hypertension, and is associated with wide range of severe complications and comorbidities. Pharmacologic treatment with vasopressin receptor antagonists offer management options beyond standard therapy.
24-Hour ICH Score Better Prognostic Indicator Than ICH Score at Admission
April 26th 2012Although the intra-cerebral hemorrhage (ICH) score at hospital admission is typically used to estimate the potential prognosis in stroke patients, a new study suggests that the 24-hour ICH score is a more accurate assessment.
Pregabalin Safe and Effective for Relief of Chronic Neuopathic Pain and Related Sleep Disturbance
April 26th 2012According to a randomized, controlled clinical trial reported at the Emerging Science session, pregabalin was found effective in relieving chronic neuropathic pain and pain-related sleep disturbances associated with spinal cord injury.
Levodopa-Carbidopa Intestinal Gel Prolongs Treatment Benefit In Parkinson's Disease
April 25th 2012The 2012 Annual Meeting of the American Academy of Neurology presented a phase 3 randomized, double-blind clinical trial which found that levodopa-carbidopa intestinal gel was more effective than standard oral levodopa-carbidopa.
Potential Diagnostic Tool for Early Alzheimer's Disease
April 24th 2012A new study presented at the 2012 Annual Meeting of the American Academy of Neurology suggests that the drug florbetaben can be used as a biomarker with positron emission tomography (PET) imaging to diagnose AD by detecting amyloid plaques in the brains of living people suspected of having AD.